Early combination of albumin with crystalloids administration might be beneficial for the survival of septic patients: a retrospective analysis from MIMIC-IV database by Shiyu Zhou, Zhenhua Zeng, Hongxia Wei, Tong Sha, Shengli An

Subjects: Get full text

The restricted mean survival time as a replacement for the hazard ratio and the number needed to treat in long‐term studies by Andrea Messori, Laura Bartoli, Sabrina Trippoli

Subjects: “…Restricted mean survival time…”
Get full text

Definition and Estimation of Covariate Effect Types in the Context of Treatment Effectiveness by Yasutaka Chiba

Subjects: Get full text

Eight‐Year Outcomes of Cardiosphere‐Derived Cells in Single Ventricle Congenital Heart Disease by Kenta Hirai, Ryusuke Sawada, Tomohiro Hayashi, Toru Araki, Naomi Nakagawa, Maiko Kondo, Kenji Yasuda, Takuya Hirata, Tomoyuki Sato, Yuki Nakatsuka, Michihiro Yoshida, Shingo Kasahara, Kenji Baba, Hidemasa Oh

Subjects: Get full text

Survival outcomes of population-wide colonoscopy screening: reanalysis of the NordICC data by Tomer Meirson, Gal Markel, Daniel A. Goldstein

Subjects: Get full text

Optimal two-stage designs based on restricted mean survival time for a single-arm study by Guogen Shan

Subjects: Get full text

Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer by Shuang Zhang, Shuang Li, Yanan Cui, Peiyan Zhao, Xiaodan Sun, Ying Cheng

Subjects: Get full text

Restricted Mean Survival Time—Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors? by Cristina-Florina Pîrlog, Raluca Costache, Andreea Ioana Paroșanu, Cristina Orlov Slavu, Mihaela Olaru, Ana Maria Popa, Cristian Iaciu, Irina Niță, Pompilia Moțatu, Horia Teodor Cotan, Alexandru Vlad Oprița, Daniel Costache, Loredana Sabina Cornelia Manolescu, Cornelia Nițipir

Subjects: Get full text

Within trial comparison of survival time projections from short‐term follow‐up with long‐term follow‐up findings by João Pedro Ferreira, Brian L. Claggett, Kieran F. Docherty, Pardeep S. Jhund, Faiez Zannad, Scott D. Solomon, John J.V. McMurray

Subjects: “…Restricted mean survival time…”
Get full text

Beyond hazard ratios: appropriate statistical methods for quantifying the clinical effectiveness of immune-oncology therapies – the example of the Netherlands by Isaac Corro Ramos, Venetia Qendri, Maiwenn Al

Subjects: Get full text

Adjusted empirical likelihood analysis of restricted mean survival time for length-biased data by Zahra Mohammadian, Arezoo Habibi

Subjects: Get full text

An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use by Keri L. Calkins, Chelsea E. Canan, Richard D. Moore, Catherine R. Lesko, Bryan Lau

Subjects: Get full text

Individual patient data network meta-analysis using either restricted mean survival time difference or hazard ratios: is there a difference? A case study on locoregionally advanced... by C. Petit, P. Blanchard, JP. Pignon, B. Lueza

Subjects: Get full text

Reduction in number to treat versus number needed to treat by Chenyang Zhang, Guosheng Yin

Subjects: Get full text

Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis by Béranger Lueza, Federico Rotolo, Julia Bonastre, Jean-Pierre Pignon, Stefan Michiels

Subjects: “…Restricted mean survival time…”
Get full text

Impact of a non-constant baseline hazard on detection of time-dependent treatment effects: a simulation study by Kim Jachno, Stephane Heritier, Rory Wolfe

Subjects: Get full text

Differences of survival benefits brought by various treatments in ovarian cancer patients with different tumor stages by Tingshan He, Hong Li, Zhiqiao Zhang

Subjects: Get full text

Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated by Patrick Royston, Mahesh K.B. Parmar

Subjects: Get full text

Estimating restricted mean survival time and expected life-years lost in the presence of competing risks within flexible parametric survival models by Sarwar I. Mozumder, Mark J. Rutherford, Paul C. Lambert

Subjects: Get full text

Comparison between asymptotic and re-randomisation tests under non-proportional hazards in a randomised controlled trial using the minimisation method by Ryusei Kimura, Shogo Nomura, Kengo Nagashima, Yasunori Sato

Subjects: Get full text